From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 421,100 shares, representing 0.25% for CNY 5.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.18 CNY | +3.50% | +0.14% | -2.68% |
1st Jan change | Capi. | |
---|---|---|
-2.68% | 33Cr | |
+17.10% | 843.95Cr | |
+14.30% | 677.4Cr | |
-3.69% | 381.36Cr | |
-7.34% | 371.09Cr | |
+1.78% | 140.16Cr | |
-28.77% | 108.66Cr | |
+18.84% | 102.67Cr | |
-11.81% | 90Cr | |
-18.34% | 78Cr |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.